PrimeRFP SCOUT · Federal Contract Recompete Brief

HT001423P0027Immucor reagents — Immucor Inc

Immucor Inc holds $8.2M across 217 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards in the incumbent pipeline. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Dec 15, 2027 PoP end — agencies typically plan 12–18 months ahead.

Defense Health Agency

Awarding office

Immucor Inc

Recipient

Dec 15, 2027

PoP end

$55K

Obligated

$137K

Potential

621511

NAICS

Q301

PSC

NONE

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Immucor Inc — $90

Contract facts

NONE

Contract numberHT001423P0027

Also listed asHT0014-23-P-0027

AgencyDefense Health Agency

Awarding officeDefense Health Agency

Awarding agencyDepartment of Defense (DOD)

Funding agencyDepartment of Defense (DOD)

IncumbentImmucor Inc

CAGE64527

UEIKV8AGJX7NMZ7

NAICS621511

No full NAICS 621511 intel page yet. Browse NAICS intelligence

PSCQ301

Place of performanceCHERAW CO

Pricing typeFirm Fixed Price

Extent competedNot Competed

Related solicitationHT001423R0000

PoP startJan 31, 2023

PoP end (current)Dec 15, 2027

PoP end (w/ options)Dec 31, 2027

Obligated$55K

Current value$137K

Potential value$137K

IMMUCOR REAGENTS is a federal NONE award for Defense Health Agency held by Immucor Inc. Estimated value $137K ($55K obligated). Current period of performance ends Dec 15, 2027 (potential Dec 31, 2027). Last award drew 1 bidder. Place of performance: CHERAW CO. Related solicitation HT001423R0000.

Recompete timing

Public

● Expiring in 481 days

Current PoP ends Dec 15, 2027 (481 days remaining). Agencies typically plan 12–18 months ahead — position before the PoP clock runs out.

Incumbent footprint

Public record

Immucor Inc — $8.2M obligated across 217 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($8.2M) · all agencies

Department of Veterans Affairs (VA)$4.0M · 49%Department of Defense (DOD)$3.8M · 46%Department of Health and Human Services (HHS)$444K · 5%

Open full company profile →

Related awards

Same incumbent

N6890821F0035

SUPPLIES/SERVICES

$404K

Sep 30, 2026

36C24623P0063

BLOOD BANK REAGENTS AND CONSUMBLES

$237K

Sep 30, 2026

N0025922F0233

PANOCELL 16 16X3

$224K

Sep 30, 2026

75H71023F80334

EXERCISE OPTION

$224K

Jan 31, 2027

W81K0222P0068

REAGENTS AND USE OF ECHO LUMENA ANALYZER FOR BLOOD BANK - BASE PERIOD: 1 OCT 2022 - 30 SEP…

$1.4M

Sep 30, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract HT001423P0027?

HT001423P0027 (Immucor reagents) is a Defense Health Agency award with a potential value of $137K, currently held by Immucor Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is HT0014-23-P-0027?

HT0014-23-P-0027 is the dashed form of PIID HT001423P0027 (Immucor reagents), held by Immucor Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded HT001423P0027?

Defense Health Agency awarded HT001423P0027 to Immucor Inc (potential $137K).

Who is the incumbent on HT001423P0027?

Immucor Inc is the incumbent with $8.2M across 217 related awards in SCOUT’s public footprint. The current period of performance ends Dec 15, 2027.

When does Immucor Inc’s HT001423P0027 come up for recompete?

SCOUT tracks a period-of-performance end of Dec 15, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 25, 2026 · refreshed monthlyLatest procurement action Mar 10, 2026